NIRVANA
Non-Invasive Minimal Residual Disease (MRD) Assessment in Multiple Myeloma Via Functional Imaging and Liquid Biopsy
More Information
- Trial Status
- Accepting patients
- Enrollment
- 88 patients (estimated)
- Sponsors
- Columbia University Medical Center
- Collaborators
- Hope Foundation
- Trial Type
- Observational
- Last Update
- 1 month ago
- SparkCures ID
- 1925
- NCT Identifier
- NCT05625971
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.